Skip to main content
. 2016 Nov 22;16(3):397–405. doi: 10.1177/1534735416675951

Figure 1.

Figure 1.

TSL fractions inhibit growth in human osteosarcoma cell lines. Human osteosarcoma cells, MG-63, Saos-2, and U2OS, were treated with 0.005, 0.05, 0.5, and 5mg/mL of TSL fractions for 24 hours. At the end of treatment, the cell viability was measured by MTT assay (A). The IC50 values of MG-63, Saos-2, and U2OS cells after TSL fractions treatment (B). **P < .001.